All reported non-canonical splice site variants in GLA cause aberrant splicing.
Eri OkadaTomoko HorinouchiTomohiko YamamuraYuya AotoRyota SuzukiYuta IchikawaYu TanakaChika MasudaHideaki KitakadoAtsushi KondoNana SakakibaraShinya IshikoChina NaganoShingo IshimoriJoichi UsuiKunihiro YamagataMasafumi MatsuoKandai NozuPublished in: Clinical and experimental nephrology (2023)
Validation of splicing effects using an in vitro splicing assay is useful for confirming pathogenicity and determining associations with clinical phenotypes.